Ever - Generic Drug Details
✉ Email this page to a colleague
US Patents and Regulatory Information for ever
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa | EVEROLIMUS | everolimus | TABLET;ORAL | 210050-003 | Dec 9, 2019 | AB | RX | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
| Mylan | EVEROLIMUS | everolimus | TABLET;ORAL | 212936-003 | Jun 8, 2020 | AB | RX | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
| Amneal | EVEROLIMUS | everolimus | TABLET, FOR SUSPENSION;ORAL | 218863-002 | Jan 10, 2025 | AB | RX | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Showing 1 to 3 of 3 entries
